Sana Biotechnology (SANA) EV/FCF: History & Chart

Sana Biotechnology, Inc.(SANA)

Biotechnology · Seattle, WA

$2.81-0.07 (-2.60%)

Delayed quote: Oct 6, 2026, 3:10 PM EDT

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug candidates includes SG295 and SG242, which are designed to target CD19+ cancer cells involved in non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. For multiple myeloma, Sana is progressing SG221, SG239, and SC255. Other pipeline assets include SG328 for ornithine transcarbamylase deficiency, and SG418 for sickle cell disease and beta-thalassemia. Additionally, the company is advancing SC291, a CD19 allogeneic T cell therapy, SC451 for type I diabetes mellitus, and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Founded in 2018 as FD Therapeutics, Inc., the company adopted its current name, Sana Biotechnology, Inc., in September 2018 and is based in Seattle, Washington.

Seattle, WA

142 employees

www.sana.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Steven D. Harr

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Sana Biotechnology, Inc. (SANA)	$780.61M	N/A	N/A	N/A	N/A
Lexicon Pharmaceuticals, Inc. (LXRX)vs ›	$781.78M	N/A	3.79x	3.79x	6.31x
Geron Corporation (GERN)vs ›	$782.66M	N/A	58.32x	58.32x	58.32x
Varex Imaging Corporation (VREX)vs ›	$778.23M	N/A	28.51x	30.45x	34.63x
AdaptHealth Corp. (AHCO)vs ›	$785.03M	28.73x	18.09x	34.83x	61.33x
Attovia Therapeutics, Inc. (ATTO)vs ›	$778.20M	N/A	N/A	N/A	N/A
Gyre Therapeutics, Inc. (GYRE)vs ›	$798.82M	N/A	402.12x	246.51x	209.59x
Mesa Laboratories, Inc. (MLAB)vs ›	$761.32M	15.74x	16.95x	18.56x	27.11x
InMode Ltd. (INMD)vs ›	$803.87M	4.71x	6.37x	8.04x	13.91x
Jade Biosciences, Inc. (JBIO)vs ›	$808.16M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/FCF RATIO

TTM

Sana Biotechnology, Inc. (SANA)

$780.61M

N/A

Lexicon Pharmaceuticals, Inc. (LXRX)vs ›

$781.78M

N/A

3.79x

6.31x